| Literature DB >> 30603632 |
Yeliz Yilmaz1, Levent Tumkaya2.
Abstract
PURPOSE: To research the effects of iloprost (IL) and hyperbaric oxygen (HBO) combination treatment on lung injury and on tumor necrosis factor alpha (TNF-α), myeloperoxidase (MPO), malondialdehyde (MDA), and soluble intercellular adhesion molecule-1 (sICAM-1) levels after tissue or organ ischemia-reperfusion, and on ischemia-reperfusion induced lung neutrophil sequestration.Entities:
Keywords: Hyperbaric oxygenation; Iloprost; Reperfusion injury; Tumor necrosis factor-alpha
Year: 2018 PMID: 30603632 PMCID: PMC6306501 DOI: 10.4174/astr.2019.96.1.34
Source DB: PubMed Journal: Ann Surg Treat Res ISSN: 2288-6575 Impact factor: 1.859
Blood pH, PO2, PCO2, HCO3 levels determined at the end of the reperfusion period
Values are presented as mean ± standard deviation.
HBO, hyperbaric oxygenation; IL, iloprost.
a)Significantly lower than the treatment groups by ANOVA test (P = 0.005). b)Significantly higher than the control, sham and IL groups by analysis of variance (ANOVA) test (P = 0.001). c)Significantly higher than the treatment groups by ANOVA test (P = 0.002).
Fig. 1Preoperative, serum tumor necrosis factor alpha (TNF-α) levels in first hour of ischemia and first and fourth hours of reperfusion. HBO, hyperbaric oxygenation; IL, iloprost.
Plasma and lung tissue MDA, MPO, sICAM-1 and LDH levels determined at the end of the reperfusion period
Values are presented as mean ± standard deviation.
HBO, hyperbaric oxygenation; IL, iloprost; MDA, malondialdehyde; MPO, myeloperoxidase; sICAM-1, circulating intercellular adhesion molecule-1; LDH, lactate dehydrogenase.
a)P = 0.001 vs. Sham group. b)P = 0.005 vs. and treatment groups by analysis of variance test.
Histopathologic results determined at the end of the reperfusion period
Values are presented as mean ± standard deviation unless otherwise indicated.
IQR, interquartile range; HBO, hyperbaric oxygenation; IL, iloprost.
Fig. 2(A) Lung tissue that does not show ischemic injury (H&E, ×40). (B) Moderate degree of ischemic lung injury characterized by interstitial septal thickening, neutrophil infiltration, mild intra-alveolar edema and bleeding areas (+) (H&E, ×200). (C) Diffuse, severe ischemic lung injury characterized by bleeding, edema, interstitial congestion, and neutrophil infiltration (H&E, ×200).